FDA Adverse Event Malfunction Summary report: N

GORE EXCLUDER AAA ENDOPROSTHESIS

MDR report key: 2940516 · Received December 20, 2012

Report

Report Number
2017233-2012-00856
Event Type
Malfunction
Date Received
December 20, 2012
Date of Event
November 27, 2012
Report Date
November 27, 2012
Manufacturer
W.L. GORE & ASSOCIATES
Product Code
MIH
PMA / PMN Number
P020004
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MS, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

A REVIEW OF THE MFG RECORDS FOR THE DEVICE VERIFIED THAT THE LOT MET ALL PRE-RELEASE SPECIFICATIONS. THE GORE EXCLUDER AAA ENDOPROSTHESIS INSTRUCTIONS FOR USE (IFU) WARNS AGAINST CONTINUING TO WITHDRAW THE DELIVERY CATHETER IF RESISTANCE IS FELT DURING REMOVAL THOUGH THE INTRODUCER SHEATH. FORCIBLY WITHDRAWING THE DELIVERY CATHETER THROUGH THE INTRODUCER SHEATH WHEN RESISTANCE IS ENCOUNTERED HAS RESULTED IN ADVERSE EVENTS INCLUDING CATHETER SEPARATION AND REINTERVENTION.

Description of Event or Problem · 1

ON (B)(6) 2012, THE PT WAS IMPLANTED WITH A GORE EXCLUDER AAA ENDOPROSTHESIS TO TREAT AN ABDOMINAL AORTIC ANEURYSM. AFTER THE TRUNK-IPSILATERAL LEG COMPONENT (RMT231416 / 10450465) WAS FULLY DEPLOYED, THE PHYSICIAN FELT RESISTANCE WHILE WITHDRAWING THE DELIVERY CATHETER BACK ACROSS THE LUNDERQUIST GUIDE WIRE. THE PHYSICIAN STATED THERE MAY HAVE BEEN A BEND IN THE WIRE. THE PHYSICIAN WAS ABLE TO WITHDRAW THE DELIVERY CATHETER FROM THE SHEATH, AND REMOVED IT FROM THE PT. AS THE PHYSICIAN CONTINUED TO MOVE THE DELIVERY CATHETER ALONG THE GUIDEWIRE, WHICH WAS OUTSIDE THE PT, THERE WAS STILL RESISTANCE, AND THE CATHETER TIP WAS PULLED OFF. THE CATHETER SHAFT AND CATHETER TIP WERE EVENTUALLY REMOVED FROM THE GUIDEWIRE. THE PROCEDURE WAS COMPLETED AS PLANNED WITHOUT ANY FURTHER COMPLICATIONS. THE PT TOLERATED THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GORE EXCLUDER AAA ENDOPROSTHESIS MIH / SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W.L. GORE & ASSOCIATES 10450465

Patients

Seq Age Sex Outcome Treatment
1 80 YR